Cargando…

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient

Breast cancer is a dangerous disease that results in high mortality rates for cancer patients. Many methods have been developed for the treatment and prevention of this disease. Determining the expression patterns of certain target genes in specific subtypes of breast cancer is important for develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phan, Nam Nhut, Wang, Chih-Yang, Li, Kuan-Lun, Chen, Chien-Fu, Chiao, Chung-Chieh, Yu, Han-Gang, Huang, Pung-Ling, Lin, Yen-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805530/ https://www.ncbi.nlm.nih.gov/pubmed/29467944 http://dx.doi.org/10.18632/oncotarget.24059

Ejemplares similares

CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer
por: Li, Zhaoxing, et al.
Publicado: (2021)

The role of the CDCA gene family in ovarian cancer
por: Chen, Chongxiang, et al.
Publicado: (2020)

CDCA8 expression and its clinical relevance in patients with bladder cancer
por: Bi, Yaqiong, et al.
Publicado: (2018)

Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis
por: Ci, Chao, et al.
Publicado: (2019)

CDCA8 as an independent predictor for a poor prognosis in liver cancer
por: Shuai, Yu, et al.
Publicado: (2021)

The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Jin, Xin, et al.
Publicado: (2022)

Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells
por: Gao, Xin, et al.
Publicado: (2020)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Bioinformatics analysis of the clinical relevance of CDCA gene family in prostate cancer
por: Gu, Peng, et al.
Publicado: (2022)

Prognostic value of CDCA3 in kidney renal papillary cell carcinoma
por: Li, Hao, et al.
Publicado: (2021)

Mechanisms for Bile Acids CDCA- and DCA-Stimulated Hepatic Spexin Expression
por: Lai, Qi, et al.
Publicado: (2022)

Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Markers, Disease
Publicado: (2023)

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
por: Shen, Dexin, et al.
Publicado: (2021)

CDCA8 Contributes to the Development and Progression of Thyroid Cancer through Regulating CDK1
por: Xiang, Cheng, et al.
Publicado: (2022)

Cadmium-Containing Carbonic Anhydrase CDCA1 in Marine Diatom Thalassiosira weissflogii
por: Alterio, Vincenzo, et al.
Publicado: (2015)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

CDCA7 finely tunes cytoskeleton dynamics to promote lymphoma migration and invasion
por: Martín-Cortázar, Carla, et al.
Publicado: (2020)

KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2021)

CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2021)

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
por: Li, Tianhao, et al.
Publicado: (2023)

High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity
por: Wang, Yunhan, et al.
Publicado: (2023)

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer
por: Wan, Shun, et al.
Publicado: (2022)

Borealin/CDCA8 deficiency alters thyroid development and results in papillary tumor-like structures
por: Didier-Mathon, Hortense, et al.
Publicado: (2023)

Mutations in CDCA7 and HELLS cause immunodeficiency–centromeric instability–facial anomalies syndrome
por: Thijssen, Peter E., et al.
Publicado: (2015)

CDCA7 is a critical mediator of lymphomagenesis that selectively regulates anchorage-independent growth
por: Jiménez-P, Raúl, et al.
Publicado: (2018)

CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Wang, Zhihuai, et al.
Publicado: (2021)

CDCA2 promotes tumorigenesis and induces radioresistance in oesophageal squamous cell carcinoma cells
por: Xu, Bing, et al.
Publicado: (2021)

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
por: Tan, Jianlong, et al.
Publicado: (2022)

CDCA2 Promotes HCC Cells Development via AKT–mTOR Pathway
por: Li, Kai, et al.
Publicado: (2022)

Coevolution of the CDCA7-HELLS ICF-related nucleosome remodeling complex and DNA methyltransferases
por: Funabiki, Hironori, et al.
Publicado: (2023)

Prognostic and Immunological Roles of Cell Cycle Regulator CDCA5 in Human Solid Tumors
por: He, Jing, et al.
Publicado: (2022)

Gut Microbial Profile Changes in Patients with Gallbladder Stones after UDCA/CDCA Treatment
por: Lee, Jungnam, et al.
Publicado: (2023)

[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2023)

Coevolution of the CDCA7-HELLS ICF-related nucleosome remodeling complex and DNA methyltransferases
por: Funabiki, Hironori, et al.
Publicado: (2023)

[Retracted] KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2023)

Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma
por: Wang, Xiaoxiong, et al.
Publicado: (2021)

CDCA3 Predicts Poor Prognosis and Affects CD8(+) T Cell Infiltration in Renal Cell Carcinoma
por: Bai, Yuanyuan, et al.
Publicado: (2022)

CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway
por: Chen, Erbao, et al.
Publicado: (2023)

CDCA8 promotes bladder cancer survival by stabilizing HIF1α expression under hypoxia
por: Zhou, Qiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jhccs2cqkra85a9cedqdc92v0h